Stock
The next step in the stock market will be very interesting. I’ve been discussing a potential Q1 correction since our MarketVision event the first...
Hi, what are you looking for?
Things heated up this week on , featuring interviews with Kristina Hooper of Invesco, Keith Fitz-Gerald of The Fitz-Gerald Group, and Jordan Kimmel of...
The next step in the stock market will be very interesting. I’ve been discussing a potential Q1 correction since our MarketVision event the first...
The seismic shift of the past fortnight is hard to digest. Ukraine and its allies hope, deeply, that the plank Kyiv has been slammed...
Extremely heavy volume that accompanies a gap higher and a reversing candle after a lengthy uptrend is typically a sign of buyers’ exhaustion and...
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated...
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets....
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish...
In this edition of StockCharts TV‘s The Final Bar, Dave answers viewer questions on using technical indicators on leveraged and inverse ETFs like SOXL and SOXS,...